Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
This locus encodes a protein that may play a role in the cellular response to arterial injury through involvement in vascular remodeling. Additionally we are shipping CTHRC1 Proteins (13) and CTHRC1 Kits (12) and many more products for this protein.
Showing 10 out of 70 products:
Human Polyclonal CTHRC1 Primary Antibody for ELISA - ABIN1999033
Pyagay, Heroult, Wang, Lehnert, Belden, Liaw, Friesel, Lindner: Collagen triple helix repeat containing 1, a novel secreted protein in injured and diseased arteries, inhibits collagen expression and promotes cell migration. in Circulation research 2005
Show all 2 references for ABIN1999033
Human Polyclonal CTHRC1 Primary Antibody for EIA, WB - ABIN453589
Clark, Gurney, Abaya, Baker, Baldwin, Brush, Chen, Chow, Chui, Crowley, Currell, Deuel, Dowd, Eaton, Foster, Grimaldi, Gu, Hass, Heldens, Huang, Kim, Klimowski, Jin, Johnson, Lee, Lewis, Liao, Mark et al.: The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment. ... in Genome research 2003
Human Monoclonal CTHRC1 Primary Antibody for IHC (p), ELISA - ABIN530367
Kim, Baek, Yim, Kim, Jeong, Kang, Oh, Lee, Kim, Kim: Collagen triple helix repeat containing-1 (CTHRC1) expression in invasive ductal carcinoma of the breast: the impact on prognosis and correlation to clinicopathologic features. in Pathology oncology research : POR 2013
Human Polyclonal CTHRC1 Primary Antibody for FACS, IHC (p) - ABIN652724
Park, Kim, Jo, Kim, Hwang, Kim, Song, Lee, Koh: Collagen triple helix repeat containing-1 promotes pancreatic cancer progression by regulating migration and adhesion of tumor cells. in Carcinogenesis 2013
Expression of CTHRC1 was significantly higher in Wilms' tumor compared to the expression in the adjacent non-cancerous tissues. High tumor expression of CTHRC1 was associated with tumor size, clinical stage, histopathological type, and vascular invasion/metastasis. Patients with high CTHRC1 expression also exhibited a shorter survival.
CTHRC1 expression is significantly upregulated in human masticatory mucosa during wound healing.
CTHRC1 downregulation inhibited proliferation.
The knockdown of CTHRC1 exerts inhibitory effects on the proliferation and migration ability of glioblastoma cells.
CTHRC1 may play a role in the progression of ovarian cancer.
this study shows that the serum CTHRC1 level was significantly higher in the influenza A virus infection patients than in the healthy individuals; the influenza A virus non-structural protein NS1 (show PTPN11 Antibodies) upregulates the expression of CTHRC1 protein
Gene expression levels of three randomly selected DEGs (show DEGS1 Antibodies), VCAN (show Vcan Antibodies), COL5A1 (show COL5A1 Antibodies) and KCNJ16 (show KCNJ16 Antibodies), were examined using RT-PCR in 10 ATC (show SRPK1 Antibodies) samples.. angiogenesis was activated by the high expression of CTHRC1, VCAN (show Vcan Antibodies) and POSTN (show POSTN Antibodies), providing necessary nutrition for tumor cells
increased CTHRC1 expression is associated with advanced TNM (show ODZ1 Antibodies) stage, increased LN metastasis and tumor size, and decreased OS and DFS (show FST Antibodies), indicating that CTHRC1 may be a biomarker for prognosis of cancer patients
High CTHRC1 expression is associated with Osteosarcoma.
Authors showed that ectopic transfection of CTHRC1 in EOC cells up-regulated the expression of EMT (show ITK Antibodies) markers such as N-cadherin (show CDH2 Antibodies) and vimentin (show VIM Antibodies), and EMT (show ITK Antibodies)-associated transcriptional factor Snail (show SNAI1 Antibodies).
CTHRC1 is an osteoclast-secreted coupling factor that regulates bone remodeling.
This study demonstrated that Cthrc1 plays a negative regulatory role, fine-tuning the onset of peripheral myelination.
this is the first demonstration of Cthrc1 as a marker of the severity of the disease progression in the dystrophic muscles.
Hormonal functions of Cthrc1 include regulation of lipid storage and cellular glycogen (show GYS1 Antibodies) levels with potentially broad implications for cell metabolism and physiology.
Data show a dramatic discrepancy between ROSA26 reporter activity and Pdgfrb (show PDGFRB Antibodies) promoter driven Cre dependent myc (show MYC Antibodies)-tagged Cthrc1 transgene expression.
Downregulated by dietary beta-carotene in lungs of knockout Bcmo1 (show BCMO1 Antibodies)-deficient mice.
Cthrc1 expression overlaps considerably with those reported for TGF-beta (show TGFB1 Antibodies) family members and interstitial collagens.
Cthrc1 selectively activates the planar cell polarity pathway of Wnt signaling by stabilizing the Wnt-receptor complex.
Cthrc1 increases bone mass as a positive regulator of osteoblastic bone formation
This locus encodes a protein that may play a role in the cellular response to arterial injury through involvement in vascular remodeling. Mutations at this locus have been associated with Barrett esophagus and esophageal adenocarcinoma. Alternatively spliced transcript variants have been described.
collagen triple helix repeat containing 1
, collagen triple helix repeat-containing protein 1